Biological E Limited reduces CORBEVAX® price to Rs 250 a dose

Hyderabad, May 16 : Hyderabad-based vaccine and pharmaceutical company Biological E Limited (BE) on Monday announced that it has reduced the price of its COVID-19 Vaccine CORBEVAX®, from Rs. 840 to Rs.250 a dose inclusive of GST, for private COVID-19 vaccination centres. For the end user, the price would be Rs 400 a dose, including taxes and administration charges, BE said in a release. BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect maximum number of children against the virus. The decision comes within weeks of Biological E. Limited had received Emergency Use Authorization (EUA) for children between 5 and 12 years of age. The previous private market price for the vaccine was Rs.990 a dose including taxes and vaccine administration charges. CORBEVAX® is also offered in a single-dose vial, making it more convenient for vaccine administration. It eliminates vaccine wastage, which is a major advantage for private hospitals. The CORBEVAX® vaccination slot can be booked through the Co-WIN app or the Co-WIN portal for children aged 12 to 17, the release said. So far, 43.9 million doses of CORBEVAX® have been administered to children across the country and Biological E. Limited had supplied close to 100 Million doses to the Government of India. Biological E. Limited, in collaboration with Texas Children’s Hospital and Baylor College of Medicine, has developed a recombinant protein sub-unit vaccine for the novel coronavirus, CORBEVAX®. Prior to receiving EUA for vaccination, the company conducted Phase II and III multicentre clinical trials in 624 children aged 5-12 and 12-18, the release added


Please enter your comment!
Please enter your name here